Financial, market and economic news

Myovant Sciences Appoints Ryan Crowe as Vice President, Investor Relations

BASEL, Switzerland, Oct. 14, 2020 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE:MYOV), a healthcare company focused on redefining care for women and for men, today announced the appointment of Ryan Crowe as vice president, investor relations. In addition to managing day-to-day interactions with analysts and investors, Mr. Crowe will be responsible for developing and implementing a comprehensive and strategic global investor relations program. He will report to Frank Karbe, Myovant’s president and chief financial officer.

“We are delighted to welcome Ryan to Myovant,” said Mr. Karbe. “He brings a deep knowledge of the pharmaceutical industry and, combined with his extensive investor relations experience, will continue to strengthen Myovant’s relationship with the investment community.”

Mr. Crowe joins Myovant after nearly 16 years at Pfizer Inc., where he most recently served as senior director of investor relations and was responsible for conducting global investor relations activities for the …

Full story available on

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy